CAS: 645-05-6; N2,N2,N4,N4,N6,N6-Hexamethyl-1,3,5-Triazine-2,4,6-Triamine

该化合物是一种有机化合物,主要用作治疗某些类型癌症,特别是卵巢癌的乳胶化剂,被归类为烷基剂,这意味着它通过干扰癌症细胞的DNA而起作用,最终导致细胞死亡.甲状腺素是一种白色的,白色的,脱白的晶状粉,在有机溶剂中溶解,但在水中溶解度有限.其化学配方为C6H12N4, 其结构包括一种与甲基组相连的三聚胺核心.该化合物是口服的,并已知其相对作用相对较轻的副作用,尽管它仍然可造成恶心,呕吐和血毒.甲状腺素的动作机制涉及形成与DNA结合的活性中间体,干扰快速分裂癌症细胞的复制和转录过程.与所有乳胶化剂一样,在临床环境中的用途受到仔细监测,以平衡其潜在效果.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号1467-79-4 二甲基氰胺 | CAS号108-77-0 氰尿酰氯 | CAS号124-40-3 二甲胺 | CAS号123-39-7 N-甲基甲酰胺 | CAS号103-83-3 N,N-二甲基苄胺 | CAS号51-80-9 四甲基甲烷二胺 | CAS号506-59-2 盐酸二甲胺 | CAS号124-40-3 二甲胺 | CAS号108-80-5 氰尿酸

合成工艺路线路线简述

    二甲基氢胺置于2,9-二甲基-4,7二苯基-1,10-菲啰啉,2-Methyl-1-Propenylmagnesium Bromide,C26H20Cl2Fen2体系中,用 四氢呋喃,2-甲基四氢呋喃 作为反应溶剂,以98 %的收率获得产物六甲蜜胺
    参考文献:一种多功能,具有官能团耐受性且稳定的铁预催化剂,用于通过 [2+2+2] 环加成构建芳烃和三嗪环
    标题:一种多功能,具有官能团耐受性且稳定的铁预催化剂,用于通过 [2+2+2] 环加成构建芳烃和三嗪环
    摘要:描述了一种依赖于使用空气稳定的铁预催化剂的新的[2+2+2]环加成过程,该过程允许在绿色溶剂和温和条件下构建芳香环和含氮杂芳环.据报道,1,6-或1,7-二炔与炔之间的环加成和交叉环加成具有广泛的功能耐受性,从而产生各种可功能化的支架.
    DOI:10.1002/chem.202400096

    海关参考信息

    专利信息


    专利号:US-2004242897-A1
    优先权日:2002-07-31
    标题 :Universal support media for synthesis of oligomeric compounds
    发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
    摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:WO-2004011474-A1
    优先权日:2002-07-31
    标题:Universal support media for synthesis of oligomeric compounds
    发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
    权利人:ISIS PHARMACEUTICALS INC; GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
    摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotide and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

    专利号:US-6653468-B1
    优先权日:2002-07-31
    标 题 :Universal support media for synthesis of oligomeric compounds
    发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
    权利人:ISIS PHARMACEUTICALS INC
    摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

    专利号:US-10925977-B2
    优先权日:2006-10-05
    标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
    发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
    权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
    摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

    专利号:US-10973847-B2
    优先权日:2017-06-30
    标题 :Core-to-surface polymerization for the synthesis of star polymers and uses thereof
    发明人:JOHNSON JEREMIAH A; GOLDER MATTHEW R
    权利人:MASSACHUSETTS INST TECHNOLOGY
    摘要:Disclosed are methods, compositions, reagents, systems, and kits to prepare star polymers, as well as compositions and uses thereof. Various embodiments show that synthesis of these polymers contain low metal concentration to provide polymers for diverse biomedical applications including in vivo applications.
    湖北恒硕精细化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hengshuochem.com
    电话: 027-82200625 82830253 82832071👤
    📞湖北恒硕精细化工有限公司 ⚠️参考联系方式

    销售电话:027-82200625 82830253 82832071
    邮箱:hengshuochem@163.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    湖北恒硕化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hengshuochem.com
    企业联系电话:027-82200625;82830253👤
    📞湖北恒硕化工有限公司 ⚠️参考联系方式
    联系人:王硕 徐文琪
    电话:027-82200625;82830253
    手机:13986271535;13995541600
    传真:027-82830253
    邮箱:hengshuochem@163.com
    通信地址: 湖北省武汉市临空港经济技术开发区碧水大道7号飘轩工业园
    邮编: 430014
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北省武汉市临空港经济技术开发区碧水大道7号飘轩工业园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. Altretamine. 2016 Mar 1. 25(2):146-52. doi: 10.1177/106002809102500209. 49(6):932-53. doi: 10.2165/00003495-199549060-00007. 28(6):439-48. doi: 10.2165/00003088-199528060-00002. 18 Suppl A:31-5. doi: 10.1016/0305-7372(91)90022-r. 18 Suppl A:85-90. doi: 10.1016/0305-7372(91)90028-x. 41(9):3728-3740. doi: 10.1080/07391102.2022.2054472. Epub 2022 Mar 28.
    138:359-369. doi: 10.1016/j.ijbiomac.2019.07.093. Epub 2019 Jul 16. 88(2):118-22. doi: 10.1016/s0090-8258(02)00103-8. 69(3):226-9. doi: 10.1006/gyno.1998.5016. 92(1):368-71. doi: 10.1016/j.ygyno.2003.09.017.
    101:24-31. doi: 10.1016/j.ijbiomac.2017.03.047. Epub 2017 Mar 14. 15(1):302. doi: 10.3390/pharmaceutics15010302.

    合成参考文献


    摘要:Aggarwal, P.; Bebbington, M. W. P., Science of Synthesis Knowledge Updates, (2012) 2, 470.
    摘要:Aggarwal, P.; Bebbington, M. W. P., Science of Synthesis Knowledge Updates, (2012) 2, 433.
    摘要:Journal of Pharmacology and Experimental Therapeutics., 100(398), 1950 []
    摘要:Archives Internationales de Pharmacodynamie et de Therapie., 160(83), 1966 []
    摘要:Principles of Insect Chemosterilization, Labrecque, G.C., and C.N. Smith, eds., New York, Appleton-Century-Crofts, 1968, -(315), 1968
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知